Checkpoint Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Checkpoint Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 46% to $103,000. The net income raised on -$51,847,000 and profit margin reached -50337%. Total operating expenses were $52,251,000.
Profit Margin
| 2015 | 590K | -13.89M | -2354.58% |
|---|---|---|---|
| 2016 | 2.57M | -22.46M | -873.97% |
| 2017 | 1.72M | -22.67M | -1314.61% |
| 2018 | 3.50M | -36.36M | -1037.28% |
| 2019 | 1.70M | -24.57M | -1438.99% |
| 2020 | 1.06M | -22.96M | -2147.9% |
| 2021 | 268K | -56.61M | -21125.75% |
| 2022 | 192K | -66.91M | -34851.56% |
| 2023 | 103K | -51.84M | -50336.89% |
CKPT Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 103K | 192K | 268K | 1.06M | 1.70M | 3.50M | 1.72M | 2.57M | 590K |
Cost of revenue | 43.56M | 49.82M | 48.45M | 16.35M | 19.32M | 33.65M | 19.08M | 20.26M | 11.32M |
Gross profit | -43.46M | -49.63M | -48.18M | -15.28M | -17.61M | -30.14M | -17.35M | -17.69M | -10.73M |
Operating exp. | |||||||||
Research and development | 43.56M | 49.82M | 48.45M | 16.35M | 19.32M | 33.65M | 19.08M | 20.26M | 11.32M |
Selling and marketing | 0 | 400K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 52.25M | 58.52M | 56.99M | 24.27M | 26.55M | 40.24M | 24.5M | 24.73M | 13.81M |
Operating income | -52.14M | -58.33M | -56.72M | -23.20M | -24.85M | -36.74M | -22.77M | -22.16M | -13.22M |
Other income (expenses), net | 301K | -4.29M | 53K | 120K | 136K | 225K | 98K | -297K | -671K |
Income before tax | -51.84M | -62.62M | -56.67M | -23.08M | -24.71M | -36.36M | -22.67M | -22.46M | -13.89M |
Income tax expense | 0 | 4.29M | -53K | -120K | -136K | -521K | -22.67M | 0 | 233K |
Net income | -51.84M | -66.91M | -56.61M | -22.96M | -24.57M | -36.36M | -22.67M | -22.46M | -13.89M |
Earnings per share | |||||||||
Basic EPS | -2.77 | -7.57 | -7.45 | -4.11 | -6.96 | -12.74 | -10.03 | -10.43 | -5.69 |
Diluted EPS | -2.77 | -7.57 | -7.45 | -4.11 | -6.96 | -12.74 | -10.03 | -10.43 | -5.69 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |